In-situ self-gelling adhesive hydrogel powder for immediate sutureless closure of open ocular injuries Authors: Yajia Wang, Jiahao Wang, Zhirong Chen, Hui Wang, Peiyi Zhao, Yuemei Han, Quankui Lin Published: 2026 ABSTRACT BackgroundOpen globe injuries (OGIs) are a major cause of blindness and visual impairment, posing a significant public health challenge worldwide. Timely intervention is essential for the treatment of open eye trauma. Suturing remains the primary method for managing ocular trauma. However, suturing is time-consuming, require highly skilled physicians, and carry multiple potential risks. Therefore, there is an urgent clinical need to explore a more convenient and effective approach for ophthalmic trauma management.MethodsThis study aims to develop a rapid self- gelling adhesive hydrogel powder for sutureless wound closure in OGI. We create a water-triggered in situ self-gelling adhesive hydrogel powder based on the composite aggregation of two oppositely charged polymers (polyethyleneimine and polyacrylic acid) for rapid, sutureless closure of OGIs.ResultsThis powder can rapidly absorb interfacial water and forms in situ bonded hydrogels through strong physical interactions between polymers and between the polymer and tissue interface. The hydrogel was demonstrated to have strong tissue adhesion and excellent mechanical properties. In vitro cellular experiments and in vivo animal studies confirm its favorable biocompatibility. Animal studies demonstrated that this powder can effectively seal irregularly damaged tissue on the corneal and scleral surfaces. In conclusion, PEI/PAA powder exhibits good wet-interface adhesion and biocompatibility.ConclusionsOverall, our study demonstrate that PEI/PAA powder can rapidly absorb interfacial water to form an in-situ hydrogel. Experimental results confirm that this hydrogel exhibits strong tissue adhesion and excellent biocompatibility. These findings support the use of PEI/PAA powder as a rapid, effective, and safe therapeutic approach for OGI treatment. Introduction Ocular trauma is one of the most common causes of visual impairment and blindness worldwide [1]. According to the ophthalmology literature and the WHO Blindness Data Bank, there are approximately 55 million traumatic eye injuries each year, including 200,000 cases of open globe injuries (OGIs) [2]. OGIs are defined as full-thickness defects of the eye wall resulting from either a laceration or rupture [3]. In cases of OGIs, disruption of the ocular barrier can lead to anatomical and functional impairment, and subsequent therapeutic interventions may cause additional damage, resulting in impaired vision or even blindness. Timely intervention is essential for the management of OGIs [4]. The optimal management of OGIs requires a rapid response, demanding initial ocular repair as soon as possible after injury (within 12–24 h) to minimize complications such as endophthalmitis, intraocular hemorrhage, and internal tissue dysfunction. It has been shown that delays in one-stage repair of more than 24 h increases the risk of endophthalmitis and reduces visual acuity [5]. Therefore, there is an urgent need to develop effective emergency ocular interventions for OGIs to reduce the risk of long-term vision loss due to ocular impairment. Current standard OGI management relies primarily on surgical intervention, which consists primarily of initial suturing and optional subsequent surgical procedures. Although suturing is generally considered the gold standard in ocular surgery, it is not only time-consuming and requires advanced technical expertise, but also carries many potential risks, including infectious keratitis, aseptic infiltration, corneal neovascularization, and severe astigmatism [6, 7]. Especially in surgical procedures, surgeons typically rely solely on personal experience and tissue deformation to assess suture tension [8]. In addition, sutures are invasive and usually need to be removed later, which will cause additional damage to eye tissue. Furthermore, in developing countries where medical resources are limited but ocular trauma incidence is substantially higher, the limited availability of specialized surgical facilities and the scarcity of medical personnel result in significant delays in the management of these ocular trauma injuries. Sutureless closure methods offer distinct advantages over traditional suturing in ocular operation, which can provide many benefits, including reduced postoperative discomfort [9], reduced surgically induced astigmatism [10], faster recovery of visual acuity and fewer complications [11, 12]. Nonetheless, there is currently no suitable sutureless method for wound closure in clinical practice. Adhesives represent a promising alternative to sutures in ocular surgery [13–18]. Adhesives have shown superiority in wound closure, including rapid suture-free closure, simple operation, less pain and less scar generation, compared with traditional sutures [19]. While providing a moist environment, they also maintain a moist wound environment, absorb exudate, alleviate pain through cooling, prevent adhesion to wound tissues, protect the wound from secondary infection, and accelerate tissue regeneration [20]. Up to now, a broad range of ocular adhesives—from synthetic materials to natural polymers—have been developed, several of which have been approved for clinical use [9, 21–23]. However, these adhesives suffer from notable limitations. Among them, cyanoacrylate and fibrin glue are the two most common adhesives in ophthalmology [22]. Though cyanoacrylates have a high tensile strength, they are not recommended for use in eye surgery due to their low biocompatibility, rough surface, poor transparency, cumbersome handling. Conversely, fibrin-based adhesives have good transparency, biocompatibility, and biodegradability, making them suitable for various ophthalmic procedures (e.g., corneal perforation repair, ocular surface disease treatment, and glaucoma surgery) [21]. However, their low adhesion strength restricts their clinical utility. Developing an adhesive with strong adhesion properties is of great clinical importance for the management of OGIs. However, achieving strong wet adhesion is challenging, as displacing hydrated water from the adhesive-tissue interface is difficult [24]. The hydrated water film greatly hinders the close contact between the adhesive and the substrate, resulting in a dramatic reduction of the wet adhesion strength [25–27]. Recent studies have reported several novel adhesive materials that can absorb or remove interfacial water, thereby forming a tight bond with tissue. Cui et al. fabricated a liquid hyperbranched polymer (HBP) with a hydrophobic backbone and hydrophilic adhesive catechol side branches [25]. In contact with water, the hydrophobic chains self-aggregate to form a cohesive layer that rapidly disperses interfacial water and promotes the exposure of catecholamine groups, enabling strong interfacial adhesion. Yang et al. developed a wet-material adhesion strategy based on topological entanglement of two polymer networks [26]. A stitching polymer solution is topologically entangled with the two polymer networks of the wet material, achieving strong adhesion to biological tissues and maintaining softness. Bian’s team designed a self-gelling and adhesive polyethyleneimine and polyacrylic acid (PEI/PAA) powder, which can absorb interfacial water within 2 s and form a physically crosslinked hydrogel in situ, thereby improving the therapeutic efficacy in a rat model of gastric perforation [28]. In addition, their team reported on an ultra-fast self-gelling, wet-adhesive polyethyleneimine/polyacrylic acid/quaternized chitosan (PEI/PAA/QCS) powder as a hemostatic material and wound dressing [29]. When applied to bleeding wounds, the PEI/PAA/QCS powder rapidly absorbs large amounts of blood to achieve hemostasis, demonstrating excellent hemostatic effects on massive hemorrhage in the spleen and liver of pigs in vivo. A polyethyleneimine and polyacrylic acid-based adhesive powder exhibits excellent adhesion to wet surfaces and wound-sealing capabilities, offering significant potential for clinical application in the treatment of OGIs. Herein, we report an in-situ self-gelling adhesive powder (PEI/PAA powder) based on the complex coacervation of two oppositely charged polymers (polyethyleneimine and polyacrylic acid) for the treatment of OGIs (Scheme 1). The powder can rapidly absorb interfacial water and form in situ adhesive hydrogel with strong physical interactions between polymer-polymer and polymer-interface. We demonstrated that the hydrogel has strong tissue adhesion and excellent mechanical properties, which can effectively seal irregular corneal and scleral lesions as well as promote wound healing. With good wet interfacial adhesion, good biocompatibility, low cost, easy preparation and portable application, PEI/PAA powder is expected to be promising adhesive for the management of OGIs. Scheme 1Illustrative scheme of the fabrication of PEI/PAA powder and its application in sutureless ocular wound closure Illustrative scheme of the fabrication of PEI/PAA powder and its application in sutureless ocular wound closure Materials and methods Materials Branched PEI (Mw ≈ 25,000) aqueous solution (25 wt %), PAA (Mw ≈ 240,000) aqueous solution (25 wt%) and fluorescein isothiocyanate (FITC) were purchased from Sigma-Aldrich. Fetal bovine serum (FBS), DMEM/F12 (1:1) cell culture medium, 0.05% trypsin–EDTA, penicillin–streptomycin solution and other cell-related culture reagents were obtained from Gibco. Phosphate-buffered saline (PBS) was purchased from Boster Biotechnology. Cell Counting Kit-8 (CCK-8), Calcein/PI Cell Viability/ Cytotoxicity Assay Kit, DAPI Staining Solution, were purchased from Beyotime Biotechnology Co. Cell culture The human corneal epithelial cells (HCE-2) used in this study were purchased from ATCC (HCE-2). HCE-2 were cultured in DMEM/F-12 containing L-glutamine. The culture medium was supplemented with 15% fetal bovine serum, 5 µg/mL insulin, 10 ng/mL human epidermal growth factor, and 1% streptomycin/penicillin. The cells were incubated in 5% CO2 at 37 ◦C. Fabrication of PEI/PAA powder Firstly, aqueous solutions of PEI (Mw, ca. 25,000) and PAA (Mw, ca. 240,000) with a weight fraction of 10% were prepared separately. Equal volumes of 10 wt% PEI and 10 wt% PAA solutions were mixed. After full gel formation, excess liquid was discarded. The mixture was frozen at − 80 °C for at least 12 h and freeze-dried to remove moisture. Finally, dry solids are ground using a mortar and pestle to obtain PEI/PAA powder. Preparation of PEIFITC/PAA powder 1 g of PEI and 10 mg of FITC were dissolved in 5 mL of a 10% DMSO solution, stirred in the dark at room temperature for 24 h. The mixture was purified by dialysis (Thermo Fisher Scientific, 1 kDa MWCO cutoff) to remove DMSO and unreacted FITC. Then the aqueous PEIFITC solution was frozen at − 80 °C. After sufficient freezing, it was freeze-dried and then grinded into a powder and stored in the dark. All procedures and storage should be in the dark. The following steps were the same as for PEI/PAA powder preparation. Microscopic observation of polymer molecular diffusion PEIFITC/PAA powder was placed on a slide and then added with deionized water. Changes of PEIFITC/PAA powder/hydrogel were observed and recorded by confocal microscopy. Microscopic morphology observation Hydrogels were freeze-fixed and then freeze-dried for approximately 48 h to remove moisture. Then, the cross sections were sprayed with gold and observed by field emission scanning electron microscope (Regulus8100, Japan). Tissue adhesion properties of PEIFITC/PAA hydrogel PEIFITC/PAA powder has been pre-prepared. The mice were humanely sacrificed and the hair on the back of the mice was removed to fully expose the back skin. A 2.5 × 2 cm² piece of skin tissue was excised and immediately covered with PEIFITC/PAA powder in the dark. After it was sufficiently gelatinized, the tissue was dehydrated and frozen sectioned, and then an anti-fluorescence quencher containing DAPI was added. Fluorescent pictures were taken using a confocal laser scanning microscope (Zeiss LSM 880, Germany). Rheological measurements The rheological properties of PEI/PAA hydrogel were measured by AR2000 rotational rheometer (TA Instruments, America). Oscillation time-sweep experiments were performed under fixed strain of 1.0% and a frequency of 1 Hz at 25 °C. The frequency sweep experiments were performed at 1.0% fixed strain at 37 °C with angular frequencies swept from 0.1 rad/s to 10 rad/s. Lap shear adhesion test The lap shear test was based on a previous study [30]. PEI/PAA colloid-coated slides (7 × 2.5 cm, Citotest Scientific, China) were prepared by uniformly applying PEI/PAA powder to one end of the glass and saline was added from one side of the slide to make the powder form a gel (about 5 μm in thickness). In the experiment, PEI/PAA hydrogel was uniformly covered in a 2 cm area at the end of the glass. The two areas of glass were then placed in alignment and glued together to form a 2.5 × 2 cm2 contact area. The slides were then carefully mounted on the fixture of CMT2503 microcomputer controlled electronic universal testing machine (Sansi Yongheng Technology (Zhejiang) Co., Ltd., China) and the shear strengths of the samples were then tested at a speed of 5 mm/min (n = 5) at 20 °C. Swelling property 50 mg of PEI/PAA powder was soaked in PBS at room temperature to form a hydrogel. The gel was removed at regular time intervals, and excess water was gently blotted away with dry, lint-free paper before measuring the wet weight (Wt) (n = 3). The initial dry mass of the PEI/PAA powder was recorded as W0. The swelling ratio (Sr%) was calculated using the following formula:\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:Sr\%=\frac{{W}_{t}-{W}_{0}}{{W}_{0}}$$\end{document} In vitro biocompatibility evaluation Biocompatibility of PEI/PAA hydrogel was evaluated by co-culturing HCE-2 with PEI/PAA powder extracts. Cell counting kit-8 (CCK-8) and Live/Dead assays were utilized for evaluating the cytotoxicity. HCE-2 were added with 100 µL of complete medium at a density of 8 × 103 cells per well in 96-well plates and incubated at 37 °C with 5% CO2 for 24 h. PEI/PAA powder extracts were prepared by incubating 1 mL of complete medium with different masses (100,250,500,1000 µg) of PEI/PAA powder at 37 °C for 24 h. 100 µL of PEI/PAA powder extracts at different concentrations were added to each well containing cells for 24 h incubation. The control group received growth medium without hydrogel extract. For CCK-8 assay, 100 µL of CCK-8 working solution was added to each well according to the manufacturer’s protocol. The absorbances were then measured by a microplate reader (M5 SpectraMax, Thermo Fisher Scientific, USA) at 450 nm. For Live/Dead assay, the Calcein-AM and PI reagents were added to each well according to the instructions and incubated for 30 min at 37 °C in the dark. The fluorescent images were then photographed using an inverted fluorescence microscope (DMi8, Leica, GER). Animal model of corneoscleral laceration To evaluate the in vivo tissue adhesion and ocular wound sealing ability of PEI/PAA powder, we established an animal model of corneoscleral laceration on New Zealand White rabbits (male, 3 weeks, 2.5–3.0 kg). New Zealand White rabbits were purchased from the Animal Experiment Center of Wenzhou Medical University. All animal handling, treatment, monitoring, and evaluation procedures were conducted in accordance with the Association for Research in Vision and Ophthalmology guidelines. Animal experiment was approved by the Animal Ethical and Welfare Committee of Eye Hospital of Wenzhou Medical University (YSG25020803). The rabbit’s weight and eye condition were routinely examined before the surgery. General anesthesia was carried out by intramuscular injection of 2% pentobarbital sodium (1 mL/kg) and xylazine hydrochloride (0.2 mL/kg). The rabbits’ eyelashes were cut, and eyes were disinfected with povidone-iodine before the surgery. The surgery was performed under sterile conditions by a professional ophthalmologist using a surgical microscope. A portion of the nasal conjunctiva of the rabbit’s eye was incised to fully expose the corneoscleral area. Subsequently, a 10–12 mm corneoscleral wound on the nasal side was created using an ophthalmic scalpel. The PEI/PAA gel group was sealed with PEI/PAA powder, while the suture group was sutured with 10 − 0 eye sutures as the control group, with three rabbits in each group. PEI/PAA gel group was covered with an appropriate amount of PEI/PAA powder on the wound, and the powder was allowed to react with interfacial water to form an in situ adhesive hydrogel that sealed the wound. Slit lamp observation Slit-lamp examinations were performed at predetermined time points using a slit-lamp microscopy system (SLM-7E, Kanghua Ruiming Technology Co., Ltd) to assess therapeutic efficacy. Slit lamp examination was performed under ocular surface anesthesia. The wound condition was examined using a slit lamp at 1, 3, 7, 14, and 21 days postoperatively. Slit lamp photographs were taken at the time of examination. To obtain better images of the wound site, saline-soaked cotton swabs were used to gently guide the eyeball toward the temporal side, ensuring that the wound on the nasal side is clearly visible under the slit lamp. Histological assessment On day 21 of treatment, the experimental rabbits were anesthetized with an overdose of sodium pentobarbital and euthanized by air embolism. Their eyeballs were obtained for histological examination. The samples were dehydrated gradiently, embedded in paraffin wax. Then the samples were cut into 5 mm sections. The sectioned samples were dewaxed in xylene and stained with hematoxylin and eosin (H&E). Histopathological evaluation of the ocular tissue was performed to assess the healing of the corneoscleral laceration (3D Pannoramic SCAN, Belgium). Statistical analysis The results were expressed as mean ± standard deviation (SD). All statistical analyses were performed using GraphPad Prism and Origin software. An independent-sample t-test was used to compare between two groups. One-way analysis of variance (ANOVA) followed by appropriate post hoc tests was used to compare means among multiple groups. Statistical significance was interpreted as follows: p > 0.05, not significant (ns); p < 0.05, significant (*); p < 0.01, highly significant (**); p < 0.005, very highly significant (***); and p < 0.001, extremely significant (****). Fig. 1Synthesis and characterization of PEI/PAA powder. (a) Schematic illustration of Physical interactions between PEI and PAA. (b) Preparation of PEI/PAA powder and PEI/PAA hydrogel. (c) SEM image of PEI/PAA powder Synthesis and characterization of PEI/PAA powder. (a) Schematic illustration of Physical interactions between PEI and PAA. (b) Preparation of PEI/PAA powder and PEI/PAA hydrogel. (c) SEM image of PEI/PAA powder Results and discussion Synthesis and characterization of PEI/PAA powder Water-triggered self-gelling hydrogel powder (PEI/PAA powder) was prepared by freeze-drying and grinding the complexes formed by complex coacervation of PEI and PAA solutions, where the PEI/PAA complexes were prepared by mixing equal volumes of 10 wt% PEI (Mw ≈ 25,000) and 10 wt% PAA (Mw ≈ 240,000) solutions (Fig. 1b).Scanning electron microscopy (SEM) results showed that the PEI/PAA powder obtained by freeze-drying and grinding had a porous structure microscopically with pore sizes ranging from 20 to 50 μm (Fig. 1c). Properties of PEI/PAA hydrogel The adhesion strength of adhesive hydrogel is one of the most important properties for evaluating the adhesive-tissue interface interaction. In this study, the adhesion properties of PEI/PAA hydrogel were evaluated on slides by lap-shear test. Figure 2a showed the schematic diagram of the lap-shear test, and Fig. 2b showed the actual experimental operation. As shown in Fig. 2c, with the increase of strain, the adhesion stress of PEI/PAA hydrogel increased rapidly with strain, reaching a maximum of 3.61 MPa, followed by a gradual decrease. The swelling rate of the PEI/PAA hydrogel was investigated by placing the PEI/PAA powder into a PBS solution system. As shown in Fig. 2d, the swelling coefficient remained stable over 72 h, ranging from 115.5 ± 0.03% to 124.2 ± 0.06%. The limited swelling rate of PEI/PAA hydrogel during prolonged soaking indicates that it possesses stable failure tensile strength. Rheology tests were performed on PEI/PAA hydrogel to monitor the gelling process. When PEI/PAA powder is mixed with PBS solution, strong non-covalent interactions between the two polymers (such as electrostatic interactions and hydrogen bonding) lead to phase separation, forming a dense, polyelectrolyte-rich gel-like phase. The storage modulus (G′) and loss modulus (G″) decrease instantaneously and then rise rapidly within 10 s. Subsequently, the storage modulus (G′) remains higher than the loss modulus (G″), indicating the formation of a solid-state gel structure, indicating that the change from powder to hydrogel can be achieved within 10 s (Fig. 2e). The rheological properties of PEI/PAA hydrogel were investigated by dynamic oscillatory rheology. The storage modulus (G′) and loss modulus (G″) of PEI/PAA hydrogel vary with frequency and temperature (Fig. 2f-g). As the frequency increases, both G′ and G″ increase, with G″ slightly larger than G′. G′ increases significantly with frequency, which indicates that PEI/PAA hydrogel network is based on physical crosslinking/dynamic non-covalent bond. The loss modulus G″ remained close to the storage modulus G′, slightly higher than G′, which indicated that the dynamic cross-linking was dominant. It possessed certain formability and moderate fluidity, good biocompatibility, no hard mechanical stimulation, thereby facilitating substance diffusion. As the temperature increased, both G′ and G″ of the PEI/PAA hydrogel showed a decreasing trend. This indicates that rising temperature enhances the mobility of polymer molecular chains, gradually weakening dynamic non-covalent cross-links (hydrogen bonds, hydrophobic interactions, and molecular entanglement); the overall flexibility of the gel network increases, structural constraints weaken, and the network’s rigidity and structural density decrease; furthermore, in the temperature-dependent curves, G″ consistently remains slightly higher than G′. This indicates that the material itself is a weakly cross-linked system near the sol-gel transition, making it more sensitive to temperature; heating further promotes chain relaxation, manifesting macroscopically as temperature-responsive softening. Temperature-responsive softening at physiological temperature makes the PEI/PAA hydrogel softer, better suited for conforming to soft tissues, and less irritating, making it highly suitable for medical wound care and biocompatible applications. Tissue adhesion capability of PEIFITC/PAA hydrogel was evaluated by adhering the powder to mouse skin tissue (Fig. 2h). Representative fluorescence images reveal that the FITC-labeled PEI/PAA hydrogel closely adhered to mouse skin tissue, with a well-integrated interface. This indicated that the PEI/PAA hydrogel possessed excellent tissue adhesion capability. The diffusion of polymers during the formation of PEI/PAA hydrogel was investigated. Fluorescent PEIFITC/PAA powders by labeling PEI with fluorescein isothiocyanate (FITC) were prepared. Then the self-gelation process was monitored by confocal microscopy after its exposure to water. At 0 s, the fluorescent regions of the PEIFITC/PAA powders exhibited a dispersed distribution (Fig. 2i). At 1 min after water absorption, the powder self-gelatinized to form a hydrogel, and the hydrogel underwent swelling, resulting in the expansion of the fluorescence area. The area of the fluorescent region in the x-y plane subsequently increased with time, indicating significant polymer diffusion in the physically cross-linked hydrogel. Collectively, the physical properties of PEI/PAA hydrogel demonstrate robust mechanical performance and strong biological tissue adhesion, making it suitable for various surgical and tissue engineering applications. Fig. 2Properties of PEI/PAA hydrogel. (a) Schematic illustration of lap shear adhesion test. (b) Image of lap shear adhesion test platform setup. (c) Stress-Strain Curve of PEI/PAA hydrogel. (d) Swelling rate of PEI/PAA hydrogel (n = 3). (e) Storage modulus(G′) and loss modulus (G″) of PEI/PAA hydrogel before and after hydration. (f) The storage modulus (G′) and loss modulus (G″) as a function of frequency of PEI/PAA hydrogel. Strain = 1% and T = 37 ℃. (g) Temperature-dependent curves of storage modulus (G′) and loss modulus (G″) for PEI/PAA hydrogel. Frequency = 1 Hz. (h) Tissue adhesion properties of PEIFITC/PAA hydrogels. (i) Polymer molecular diffusion during PEI/PAA hydrogel formation Properties of PEI/PAA hydrogel. (a) Schematic illustration of lap shear adhesion test. (b) Image of lap shear adhesion test platform setup. (c) Stress-Strain Curve of PEI/PAA hydrogel. (d) Swelling rate of PEI/PAA hydrogel (n = 3). (e) Storage modulus(G′) and loss modulus (G″) of PEI/PAA hydrogel before and after hydration. (f) The storage modulus (G′) and loss modulus (G″) as a function of frequency of PEI/PAA hydrogel. Strain = 1% and T = 37 ℃. (g) Temperature-dependent curves of storage modulus (G′) and loss modulus (G″) for PEI/PAA hydrogel. Frequency = 1 Hz. (h) Tissue adhesion properties of PEIFITC/PAA hydrogels. (i) Polymer molecular diffusion during PEI/PAA hydrogel formation Cytocompatibility assessment of PEI/PAA hydrogel Biocompatibility and non-cytotoxicity are essential requirements for ocular biomaterials. In vitro cell experiments were performed to evaluate the biocompatibility and stability of PEI/PAA hydrogel. After 24 h of co-incubation with PEI/PAA hydrogel, most human corneal epithelial cells were stained green and exhibited a spindle-like morphology without significant morphological abnormalities (Fig. 3a). After 24 h of co-incubation with the PEI/PAA hydrogel extract, the results of the CCK-8 assay showed that the survival rate of HCE-2 was greater than 95%, with no statistically significant differences between groups (Fig. 3a). These results suggest good cell survival after 24 h of co-incubation with PEI/PAA hydrogel. Fig. 3Cytocompatibility of PEI/PAA hydrogel. (a) Live/dead staining of HCE-2 after 24 h of co-incubation with hydrogel (n = 3). (b) Cell viability of HCE-2 after 24 h of co-incubation with hydrogel leachate (n = 3). Data are shown as mean ± SD Cytocompatibility of PEI/PAA hydrogel. (a) Live/dead staining of HCE-2 after 24 h of co-incubation with hydrogel (n = 3). (b) Cell viability of HCE-2 after 24 h of co-incubation with hydrogel leachate (n = 3). Data are shown as mean ± SD In vivo assessment of PEI/PAA hydrogel in a rabbit corneoscleral lacerations model In vivo experiments were conducted to validate the repair efficacy of PEI/PAA hydrogel. In this study, a corneoscleral wound of approximately 10–12 mm was established and sealed with PEI/PAA powder (Fig. 4a). Postoperatively, the wound condition was examined using a slit lamp on days 1, 3, 7, 14, and 21, respectively. At 1, 3, and 7 days after surgery, the PEI/PAA hydrogel remained intact and adhered to the ocular surface. On the 14th day, it was found that the wound healing in the PEI/PAA treatment group was good, while the control group treated with suturing showed significant corneal neovascularization at suture site, indicating better wound healing in the PEI/PAA treatment group (Fig. 4b). All animals showed mild to moderate conjunctival congestion from day 1 to day 21, which was considered an adaptive immune response to surgery and adhesive integration. Significant relief of conjunctival congestion was observed in the PEI/PAA gel treated group from the seventh postoperative day onwards but persisted or even intensified in the suture-treated control group. During the experiment, slit-lamp examination revealed that the gel in the experimental group gradually decreased in volume and turned yellow. It is hypothesized that this is due to the gradual decomposition of the gel caused by the flushing action of tears on the ocular surface during the healing process, which also avoids tissue damage that would result from a second removal of the gel. The change in gel color may be attributed to the deposition of tears and ocular secretions within the gel matrix, or to the gel’s degradation over time. In the sutured eye, since no PEI/PAA powder was used, no yellow substance was present. H&E staining of corneal tissue sections revealed significant inflammatory cell infiltration and severe scar tissue proliferation in the suture group. Compared to the suture group, the PEI/PAA group demonstrated superior wound healing and reduced inflammatory response (Fig. 4c). The PEI/PAA group showed good recovery with a relatively smooth wound surface. In summary, PEI/PAA hydrogel demonstrates excellent wound closure capability and biocompatibility for ocular applications. Fig. 4PEI/PAA hydrogel for corneoscleral laceration treatment. (a) Schematic illustration of PEI/PAA hydrogel for the treatment of corneoscleral lacerations in rabbits. (b) Representative slit-lamp micrographs of the operated eyes at different postoperative time points for each group (Blue arrows: suture sites, yellow arrows: hydrogel fixation sites, and black arrows: cotton swabs used to assist ocular rotation) (n = 3). (c) Representative image of HE-stained corneal tissue (n = 3) PEI/PAA hydrogel for corneoscleral laceration treatment. (a) Schematic illustration of PEI/PAA hydrogel for the treatment of corneoscleral lacerations in rabbits. (b) Representative slit-lamp micrographs of the operated eyes at different postoperative time points for each group (Blue arrows: suture sites, yellow arrows: hydrogel fixation sites, and black arrows: cotton swabs used to assist ocular rotation) (n = 3). (c) Representative image of HE-stained corneal tissue (n = 3) Conclusion In this work, we developed a self-adhesive powder based on charged polyelectrolyte complexes. After mixing PEI and PAA aqueous solutions in a 1:1 weight ratio, strong noncovalent interactions (e.g., electrostatic interactions and hydrogen bonding) induced phase separation, forming a dense polyelectrolyte-rich gel phase, which has a higher storage modulus (G′) than the loss modulus (G″). After freeze-drying and milling, PEI/PAA powder was obtained. Upon contact with water, the powder fragments undergo rapid self-healing, forming a cohesive hydrogel mass with strong tissue adhesion properties. Thus, the change from powder to hydrogel upon hydration allows for rapid (within 10 s) establishment of initial bonding. In vitro cellular experiments, the PEI/PAA hydrogel exhibited no significant cytotoxicity, demonstrating good cellular safety. The results of preliminary animal experiments verified that PEI/PAA hydrogel holds potential for the treatment of corneal-scleral lacerations in the eye. Relative to conventional suture therapy, this hydrogel-based strategy shows tentative trends in accelerating wound healing and reducing suture-induced neovascularization, with encouraging in vivo therapeutic outcomes. It can promote ocular wound healing and avoid the problem of neovascularization caused by sutures. However, there are still have several limitations, including a relatively small animal sample size (n = 3 per group) and a short observation duration (only 28 days). Given the limited sample scale and insufficient long-term monitoring, the long-term biocompatibility, safety, and therapeutic stability of the PEI/PAA hydrogel cannot be fully validated. Further investigations with enlarged sample sizes, prolonged observational periods, and systematic preclinical verification, as well as subsequent clinical trials, are essential to support the future clinical translation and practical application of this novel ophthalmic adhesive. Collectively, this novel ocular adhesive may serve as a promising alternative to conventional microsurgical suturing. Traditional suturing is technically demanding, associated with elevated infection risk, and highly dependent on specialized medical resources. By contrast, the adhesive can be conveniently applied even in primary care settings. It offers low costs, fewer complications, and is easy to apply, showing potential to improve the preservation rate of the eyeball and functional outcomes in OGIs. For developing countries and remote areas with inadequate basic medical infrastructure, the non-invasive suturing method using PEI/PAA powder holds significant clinical value.